Premium
Maternal manifestation of B allantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma
Author(s) -
Takahashi Hironori,
Matsubara Shigeki,
Kuwata Tomoyuki,
Ohkuchi Akihide,
Mukoda Yukiko,
Saito Koyomi,
Usui Rie,
Suzuki Mitsuaki
Publication year - 2014
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.12286
Subject(s) - medicine , fetus , edema , lung , etiology , pulmonary edema , pregnancy , pathology , obstetrics , genetics , biology
Various fetal or placental disorders cause B allantyne's (mirror) syndrome. For the first time, we report a maternal manifestation of B allantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma ( CMN ). In a pregnant woman with a CMN fetus, lung edema, hypertension, hyperthyroidism, and high serum human chorionic gonadotrophin level occurred, all of which characterize maternal manifestation of B allantyne's syndrome. The fetus and placenta were devoid of ‘edema’, lacking ‘triple edema’, and thus this condition was not diagnosed as B allantyne's syndrome; however, we considered this condition as the maternal manifestation of B allantyne's syndrome. We performed emergent cesarean section at 28 weeks. Delivery acutely ameliorated maternal symptoms. Tumor was resected and was confirmed as CMN . Maternal manifestations of B allantyne's syndrome, such as lung edema and hypertension, can occur in a mother with fetal CMN even without fetal and/or placental edema. The clinical course of this patient may suggest an etiology of B allantyne's syndrome.